Conformational Quenching in an Engineered Lipocalin Protein Achieves High Affinity Binding to the Toxin Colchicine
Artikel i vetenskaplig tidskrift, 2025

The engineered lipocalin Colchicalin binds the clinically relevant plant toxin colchicine with picomolar affinity. X-ray structures revealed major loop rearrangements at the open end of the β-barrel upon ligand binding, suggesting a critical role for protein dynamics. Here, we integrated solution NMR relaxation experiments with molecular dynamics (MD) simulations and Markov modelling to examine conformational dynamics in the free and ligand-bound Colchicalin on the picosecond-to-millisecond timescale. Fast backbone dynamics were comparable in the presence and absence of colchicine, indicating preserved secondary structure. However, large-scale fluctuations in the structurally variable loops on the microsecond-to-millisecond timescale were observed in the apo form. We identified conformational exchange between three states, binding competent, partially closed and fully closed, characterised by loop L3 rearrangements. Colchicine binding quenches these motions, indicating a strong interplay between protein dynamics and ligand recognition. Our results support conformational selection over induced fit as the binding mechanism, highlighting the critical role of slow-timescale dynamics to enable specific, high-affinity ligand recognition and providing an important example for rational drug design.

Protein dynamics

Molecular dynamics

Conformational selection

Anticalin

NMR spectroscopy

Författare

Mark J. Bostock

Molecular Targets and Therapeutics Center

Bayerisches NMR-Zentrum, Garching bei München

Christopher Kolloff

Chalmers, Data- och informationsteknik, Data Science och AI

Elena Jerschke

Technische Universität München

Sam Asami

Bayerisches NMR-Zentrum, Garching bei München

Arne Skerra

Technische Universität München

Simon Olsson

Chalmers, Data- och informationsteknik, Data Science och AI

Michael Sattler

Bayerisches NMR-Zentrum, Garching bei München

Molecular Targets and Therapeutics Center

Angewandte Chemie

14337851 (ISSN) 15213773 (eISSN)

Vol. In Press

Ämneskategorier (SSIF 2025)

Molekylärbiologi

DOI

10.1002/anie.202515950

PubMed

41144873

Mer information

Senast uppdaterat

2025-11-03